A Case of Management for Hepatocellular Carcinoma with Lung Metastasis.
10.17998/jlc.2016.16.2.129
- Author:
Han Jo JEON
1
;
Tae Hyung KIM
;
Soon Ho UM
;
Yeon Seok SEO
;
Hyun Seo KIM
;
Ki Joon LIM
;
Seung Woon PARK
;
Han Ah LEE
;
Dong Sik KIM
Author Information
1. Department of Internal Medicine, Korea University Anam Hospitial, Seoul, Korea. lacid@korea.ac.kr
- Publication Type:Case Report
- Keywords:
Hepatocellular carcinoma;
Metastasis;
Molecular targeted therapy;
Chemotherapy
- MeSH:
Carcinoma, Hepatocellular*;
Catheter Ablation;
Drug Therapy;
Humans;
Korea;
Life Expectancy;
Liver Neoplasms;
Lung*;
Molecular Targeted Therapy;
Neoplasm Metastasis*
- From:Journal of Liver Cancer
2016;16(2):129-133
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Liver cancer is the 2nd most common cause of cancer related death in Korea. Especially, patients who present extrahepatic spread of hepatocellular carcinoma (HCC) have a shorter life expectancy (50% survival at 1 year and less than 4 months of median overall survival). Molecular target agent like sorafenib was usually mentioned as a treatment for them, but that was still not firmly established. We present a 75 year-old who had expanding nodular type of HCC. The mass was removed by resection and radiofrequency ablation. However, lung metastasis were revealed shortly after surgery. That lesions were treated with lenvatinib and systemic chemotherapy.
